Chondroitin Sulfate for Cartilage Regeneration, Administered Topically Using a Nanostructured Formulation
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251810023 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Marta E Bustos Araya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigaciones Farmacéuticas, Facultad de Farmacia, Universidad de Costa Rica, San José 11501, Costa Rica. Hauptthemen laut MEDLINE: Chondroitin Sulfates, Nanoparticles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Innovation, Technology, and Telecommunications of Costa Rica, Universitat de Barcelona.
Abstract (Originalsprache)
In the pharmaceutical sector, solid lipid nanoparticles (SLN) are vital for drug delivery incorporating a lipid core. Chondroitin sulfate (CHON) is crucial for cartilage health. It is often used in osteoarthritis (OA) treatment. Due to conflicting results from clinical trials on CHON’s efficacy in OA treatment, there has been a shift toward exploring effective topical systems utilizing nanotechnology. This study aimed to optimize a solid lipid nanoparticle formulation aiming to enhance CHON permeation for OA therapy. A 3 × 3 × 2 Design of these experiments determined the ideal parameters: a CHON concentration of 0.4 mg/mL, operating at 20,000 rpm speed, and processing for 10 min for SLN production. Transmission electron microscopy analysis confirmed the nanoparticles’ spherical morphology, ensuring crucial uniformity for efficient drug delivery. Cell viability assessments showed no significant cytotoxicity within the tested parameters, indicating a safe profile for potential clinical application. The cell internalization assay indicates successful internalization at 1.5 h and 24 h post-treatment. Biopharmaceutical studies supported SLNs, indicating them to be effective CHON carriers through the skin, showcasing improved skin permeation and CHON retention compared to conventional methods. In summary, this study successfully optimized SLN formulation for efficient CHON transport through pig ear skin with no cellular toxicity, highlighting SLNs’ potential as promising carriers to enhance CHON delivery in OA treatment and advance nanotechnology-based therapeutic strategies in pharmaceutical formulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Investigaciones Farmacéuticas, Facultad de Farmacia, Universidad de Costa Rica, San José 11501, Costa Rica.
- Pharmacy, Pharmaceutical Technology and Physico-Chemical Department, Universitat de Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.
- Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain.
- IDIBELL-UB Research Group, Pharmacotherapy, Pharmacogenomics and Pharmaceutical Technology, Avinguda Granvia, 199-203, 08908 L'Hospitalet de Llobregat, Spain.
ORCID-Profile: Anna Nardi-Ricart, Ana C Calpena Capmany, Montserrat Miñarro Carmona
Förderung
- Ministry of Science, Innovation, Technology, and Telecommunications of Costa Rica
- Universitat de Barcelona
Zitieren
APA
Bustos Araya, M. E., Nardi-Ricart, A., Calpena Capmany, A. C., & Miñarro Carmona, M. (2024). Chondroitin Sulfate for Cartilage Regeneration, Administered Topically Using a Nanostructured Formulation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251810023
Vancouver
Bustos Araya ME, Nardi-Ricart A, Calpena Capmany AC, Miñarro Carmona M. Chondroitin Sulfate for Cartilage Regeneration, Administered Topically Using a Nanostructured Formulation. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251810023
BibTeX
@article{BustosAraya2024,
author = {Bustos Araya, Marta E and Nardi-Ricart, Anna and Calpena Capmany, Ana C and Miñarro Carmona, Montserrat},
title = {Chondroitin Sulfate for Cartilage Regeneration, Administered Topically Using a Nanostructured Formulation},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251810023}
}
EUVIMED